Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Efficacy and Safety of a Proposed Omalizumab Biosimilar Compared to the Reference Product in the Management of Uncontrolled Moderate-To-Severe Allergic Asthma: A Multicenter, Phase Iii, Randomized, Double-Blind, Equivalency Clinical Trial
Morteza Sadinejad
Morteza Sadinejad

Assistant Professor of Pediatrics

Department of Pediatrics, School of Medicine

Imam Hossein Children's Hospital

Isfahan University of Medical Sciences